AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionAscent Wealth Partners, LLC
Latest Disclosed Ownership59,958 shares
Latest Disclosed Value $ 13,040,254
Ascent Wealth Partners, LLC reports 2.51% increase in ownership of 4AB / AbbVie Inc.

On May 6, 2026 - Ascent Wealth Partners, LLC filed a 13F-HR form disclosing ownership of 59,958 shares of AbbVie Inc. (BG:4AB) valued at $13,040,254 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 58,492 shares of AbbVie Inc.. This represents a change in shares of 2.51% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 59,958 1,466 2.51 13,040 -2.42 1.5157
2026-02-02 2025-12-31 13F ABBVIE COM 00287Y109 58,492 -1,013 -1.70 13,365 -3.00 1.5380
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 59,505 -759 -1.26 13,778 23.16 1.5982
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 60,264 -2,710 -4.30 11,186 -15.22 1.3804
2025-05-02 2025-03-31 13F ABBVIE COM 00287Y109 62,974 3,132 5.23 13,194 24.09 1.7696
2025-02-04 2024-12-31 13F ABBVIE COM 00287Y109 59,842 581 0.98 10,634 -9.14 1.4338
2024-10-31 2024-09-30 13F ABBVIE COM 00287Y109 59,261 -594 -0.99 11,703 13.99 1.6307
2024-07-31 2024-06-30 13F ABBVIE COM 00287Y109 59,855 -408 -0.68 10,266 -6.44 1.5033
2024-05-01 2024-03-31 13F ABBVIE COM 00287Y109 60,263 134 0.22 10,974 17.76 1.6293
2024-01-22 2023-12-31 13F ABBVIE COM 00287Y109 60,129 696 1.17 9,318 5.18 1.5216
2023-10-20 2023-09-30 13F ABBVIE COM 00287Y109 59,433 -634 -1.06 8,859 10.97 1.6317
2023-08-04 2023-06-30 13F ABBVIE COM 00287Y109 60,067 5,597 10.28 7,984 -7.11 1.4064
2023-04-25 2023-03-31 13F ABBVIE COM 00287Y109 54,470 809 1.51 8,595 -0.85 1.7272
2023-02-02 2022-12-31 13F ABBVIE COM 00287Y109 53,661 -946 -1.73 8,669 18.27 1.8640
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 54,607 -3,601 -6.19 7,329 -17.78 1.7462
2022-08-10 2022-06-30 13F ABBVIE COM 00287Y109 58,208 -1,207 -2.03 8,914 -7.45 2.0049
2022-05-02 2022-03-31 13F AbbVie COM 00287Y109 59,415 2,499 4.39 9,632 24.98 1.8006
2022-01-27 2021-12-31 13F AbbVie COM 00287Y109 56,916 -2,606 -4.38 7,707 20.03 1.3721
2021-11-01 2021-09-30 13F AbbVie COM 00287Y109 59,522 -909 -1.50 6,421 -5.67 1.2285
2021-07-30 2021-06-30 13F AbbVie COM 00287Y109 60,431 244 0.41 6,807 4.51 1.2985
2021-04-26 2021-03-31 13F AbbVie COM 00287Y109 60,187 1,204 2.04 6,513 3.05 1.4139
2021-02-02 2020-12-31 13F AbbVie COM 00287Y109 58,983 228 0.39 6,320 22.81 1.4058
2020-10-22 2020-09-30 13F AbbVie COM 00287Y109 58,755 1,114 1.93 5,146 -9.07 1.3157
2020-07-21 2020-06-30 13F AbbVie COM 00287Y109 57,641 1,204 2.13 5,659 31.60 1.6421
2020-04-29 2020-03-31 13F AbbVie COM 00287Y109 56,437 403 0.72 4,300 -13.32 1.5729
2020-01-29 2019-12-31 13F AbbVie COM 00287Y109 56,034 -91 -0.16 4,961 16.73 1.4107
2019-10-22 2019-09-30 13F AbbVie COM 00287Y109 56,125 492 0.88 4,250 5.12 1.3011
2019-07-30 2019-06-30 13F AbbVie COM 00287Y109 55,633 870 1.59 4,043 -8.38 1.2492
2019-05-13 2019-03-31 13F AbbVie Equity 00287Y109 54,763 3,298 6.41 4,413 -7.00 1.4367
2019-02-13 2018-12-31 13F AbbVie Equity 00287Y109 51,465 1 0.00 4,745 -2.51 1.8538
2019-08-21 2018-09-30 13F AbbVie COM 00287Y109 51,464 1,188 2.36 4,867 4.49 1.5525
2019-08-21 2018-06-30 13F AbbVie COM 00287Y109 50,276 1,169 2.38 4,658 0.22 1.6384
2019-08-21 2018-03-31 13F AbbVie COM 00287Y109 49,107 -84 -0.17 4,648 -2.31 1.6896
2019-08-21 2017-12-31 13F AbbVie COM 00287Y109 49,191 379 0.78 4,758 9.71 1.7715
2019-08-21 2017-09-30 13F AbbVie COM 00287Y109 48,812 -140 -0.29 4,337 22.17 1.7364
2019-08-21 2017-06-30 13F AbbVie COM 00287Y109 48,952 -450 -0.91 3,550 10.28 1.5268
2019-08-21 2017-03-31 13F AbbVie COM 00287Y109 49,402 460 0.94 3,219 5.02 1.4526
2019-08-21 2016-12-31 13F AbbVie COM 00287Y109 48,942 69 0.14 3,065 -0.58 1.5034
2019-08-21 2016-09-30 13F AbbVie COM 00287Y109 48,873 -138 -0.28 3,083 1.62 1.5588
2019-08-21 2016-06-30 13F AbbVie COM 00287Y109 49,011 260 0.53 3,034 8.94 1.5713
2019-08-21 2016-03-31 13F AbbVie COM 00287Y109 48,751 515 1.07 2,785 -2.35 1.4953
2019-08-21 2015-12-31 13F AbbVie COM 00287Y109 48,236 710 1.49 2,852 10.29 1.5912
2019-08-21 2015-09-30 13F AbbVie COM 00287Y109 47,526 360 0.76 2,586 -18.37 1.5437
2019-08-21 2015-06-30 13F AbbVie COM 00287Y109 47,166 525 1.13 3,168 16.00 1.7426
2019-08-21 2015-03-31 13F AbbVie COM 00287Y109 46,641 15,590 50.21 2,731 34.40 1.4938
2019-08-21 2014-12-31 13F AbbVie COM 00287Y109 31,051 804 2.66 2,032 16.31 1.1932
2019-08-21 2014-09-30 13F AbbVie COM 00287Y109 30,247 65 0.22 1,747 2.52 1.1097
2019-08-21 2014-06-30 13F AbbVie COM 00287Y109 30,182 615 2.08 1,704 12.18 1.0766
2019-08-22 2014-03-31 13F AbbVie COM 00287Y109 29,567 445 1.53 1,519 -1.24 1.0420
2019-08-22 2013-12-31 13F AbbVie COM 00287Y109 29,122 29,122 1,538 1.0903
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.